| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170605 Activation gene expression of slug gene; transplant or gene therapy; sexual disorders; fertility |
| 09/02/2004 | CA2516371A1 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452595A1 ES CELLS WITH ENHANCED RNAi EFFECT |
| 09/01/2004 | EP1452540A2 Molecular sequence of swine retrovirus and methods of use |
| 09/01/2004 | EP1452183A1 Use of PGRP, LRRP and CTL proteins to trigger an anti-Plasmodium immune response in Anopheles species |
| 09/01/2004 | EP1452093A1 Chimeric nonhuman animal |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1451332A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
| 09/01/2004 | EP1451330A1 Methods of preparing a targeting vector and uses thereof |
| 09/01/2004 | EP1451316A2 Method for producing transgenic birds and fish |
| 09/01/2004 | EP1451315A2 Human coagulation factor vii polypeptides |
| 09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1450602A2 Identifying and characterizing genes |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1070030B1 Treatment of waste materials |
| 09/01/2004 | CN1524411A Method for sex determination of cow calving |
| 09/01/2004 | CN1164757C Method for reproducing fly maggot with transgenic antibacterial peptide |
| 09/01/2004 | CN1164192C Production process for dehydration storage fresh-keeping of mulberry leaf |
| 08/31/2004 | US6784336 Method of producing mutant mice |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783756 Methods for regulating gene expression |
| 08/31/2004 | US6782768 Flow cytometer nozzle |
| 08/26/2004 | WO2004072282A1 Nephropathy-associated gene |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072227A2 Animal testing procedure |
| 08/26/2004 | WO2004072098A2 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | WO2004071272A2 Animal selected for lacking heparan sulfate 3-o-sulfotransferase-1 and uses thereof |
| 08/26/2004 | WO2004071269A2 Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same |
| 08/26/2004 | WO2004071185A1 An animal model |
| 08/26/2004 | WO2004044145A3 Compositions and methods for enhancing disease resistance in fish |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004011615A3 USES OF CIRCADIAN GENE mPER2 |
| 08/26/2004 | WO2002079447A8 Avian lysozyme promoter |
| 08/26/2004 | US20040168210 for drug screening anticancer/osteoporosis agents; animal models; genetic engineering |
| 08/26/2004 | US20040168209 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby |
| 08/26/2004 | US20040168208 can be used to treat and/or prevent organophosphate pesticide/nerve gas poisoning, cocaine intoxication, and succinylcholine-induced apnea; genetic engineering |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040166578 can improve the quality of the resulting blastocyst and can raise the ratio of the development into fetus and infant after transfer; genetic engineering |
| 08/26/2004 | US20040166061 drug screening for antidiabetic or antiobesity agents by determining whether a test compound activates expression of the human transcription factor gene FKHL14/FOXC2, winged helix protein; using mouse model of obesity to test the potential drug |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515203A1 Immunocompromised rodents as dual color tumor models |
| 08/25/2004 | EP1449925A1 Method of diagnosis of type 2 diabetes |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449432A1 Nonhuman model animal of systemic lupus erythematosus |
| 08/25/2004 | EP1449431A1 Sgrf genetically modified nonhuman animal |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP0983391B1 Method for diagnosing alzheimer disease |
| 08/25/2004 | EP0839208B1 A method for promoting enzyme diversity |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | CN1524122A Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 08/25/2004 | CN1524121A Method of nuclear transfer |
| 08/25/2004 | CN1523112A Tetracycline-regulated transcriptional modulators |
| 08/25/2004 | CN1163195C Bag for packaging liquid substances for animal artificial insemination |
| 08/25/2004 | CN1163122C Turtle and tortoise cultivation device |
| 08/24/2004 | US6781030 By combining a genome from an activated donor cell with an activated enucleated oocyte to obtain a nuclear transfer embryo, and impregnating an animal with the nuclear transfer embryo in conditions suitable for gestation of a cloned animal |
| 08/24/2004 | US6781029 Transgenic mouse for use as model in diagnosis and treatment of nervous and brain disorders |
| 08/24/2004 | US6781028 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 08/24/2004 | US6780644 For catalyzing site-specific resolution (deletion) of dna sequences when the two target sequences in a plasmid (extrachromosomal target) introduced in the cell by transfection |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780610 Identification of a smooth muscle cell (SMC) specific smooth muscle heavy chain (SM-MHC) promoter/enhancer |
| 08/24/2004 | CA2173626C B1k chain of laminin and methods of use |
| 08/19/2004 | WO2004070031A1 Plant-origin genes inducing cell death |
| 08/19/2004 | WO2004070002A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004027029A3 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells |
| 08/19/2004 | WO2003060084A3 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 08/19/2004 | US20040163147 Nucleic acid sequences comprising pericentric heterochromatic region of a chromosome and nucleotide sequences which confer disease resistance to plants for use in generation of satellite DNA based artificial chromosomes |
| 08/19/2004 | US20040163141 Genetic manipulation of spermatogonia |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163137 PG-3 and biallelic markers thereof |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162414 Method for reducing or preventing modification of a polypeptide in solution |
| 08/19/2004 | US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161408 Uses of circadian gene mPer2 |
| 08/19/2004 | US20040159288 Aquaculture of marine worms |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1446486A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/18/2004 | EP1446482A2 Compositions and methods for making mutations in cell lines and animals |
| 08/18/2004 | EP1446004A1 Exogenous protein expression system in an avian system |
| 08/18/2004 | EP0951533A4 Vectors and methods for the mutagenesis of mammalian genes |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522108A Process for storing enriched nematodes |
| 08/18/2004 | CN1521260A Drosophila disease model for screening drug of restoring cranial nerve cell degeneration and constructing method and application thereof |
| 08/18/2004 | CN1521259A Drosophila disease model for screening anti-dementia drug and constructing method and application thereof |
| 08/18/2004 | CN1162071C American large roach cultivation method |
| 08/18/2004 | CN1162070C Method for breeding triploid golden carp (common carp) and apparatus thereof |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777236 Process for producing a neuronal host cell in vitro comprising regulatory sequences of the β2-subunit of the neuronal nicotinic acetylcholine receptor |
| 08/17/2004 | US6777203 Telomerase promoter driving expression of therapeutic gene sequences |
| 08/17/2004 | US6776988 Vectors for gene mutagenesis and gene discovery |
| 08/17/2004 | US6776568 Treatment of waste materials |